AP2000001963A0 - Paroxetine ascorbate. - Google Patents
Paroxetine ascorbate.Info
- Publication number
- AP2000001963A0 AP2000001963A0 APAP/P/2000/001963A AP2000001963A AP2000001963A0 AP 2000001963 A0 AP2000001963 A0 AP 2000001963A0 AP 2000001963 A AP2000001963 A AP 2000001963A AP 2000001963 A0 AP2000001963 A0 AP 2000001963A0
- Authority
- AP
- ARIPO
- Prior art keywords
- paroxetine ascorbate
- paroxetine
- ascorbate
- useful
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
| PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2000001963A0 true AP2000001963A0 (en) | 2000-12-31 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/2000/001963A AP2000001963A0 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (id) |
| JP (1) | JP2002513019A (id) |
| KR (1) | KR20010042977A (id) |
| CN (1) | CN1297448A (id) |
| AP (1) | AP2000001963A0 (id) |
| AU (1) | AU3618499A (id) |
| BG (1) | BG104940A (id) |
| BR (1) | BR9909868A (id) |
| CA (1) | CA2330055A1 (id) |
| EA (1) | EA200001104A1 (id) |
| GB (1) | GB9808896D0 (id) |
| HU (1) | HUP0102116A3 (id) |
| ID (2) | ID26654A (id) |
| IL (1) | IL139081A0 (id) |
| NO (1) | NO20005352L (id) |
| PL (1) | PL343677A1 (id) |
| SK (1) | SK15912000A3 (id) |
| TR (1) | TR200003084T2 (id) |
| WO (1) | WO1999055698A1 (id) |
| ZA (1) | ZA200005912B (id) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| JP4508646B2 (ja) | 2002-01-09 | 2010-07-21 | エミスフェアー・テクノロジーズ・インク | ４−［（４−クロロ−２−ヒドロキシベンゾイル）アミノ］ブタン酸ナトリウムの多形体 |
| CN110607553B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Application Discontinuation
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352L/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1297448A (zh) | 2001-05-30 |
| SK15912000A3 (sk) | 2001-04-09 |
| AU3618499A (en) | 1999-11-16 |
| NO20005352D0 (no) | 2000-10-24 |
| ID26083A (id) | 2000-11-23 |
| EP1089995A1 (en) | 2001-04-11 |
| BR9909868A (pt) | 2000-12-19 |
| HUP0102116A3 (en) | 2002-12-28 |
| ID26654A (id) | 2001-01-25 |
| EA200001104A1 (ru) | 2001-04-23 |
| CA2330055A1 (en) | 1999-11-04 |
| GB9808896D0 (en) | 1998-06-24 |
| JP2002513019A (ja) | 2002-05-08 |
| TR200003084T2 (tr) | 2001-02-21 |
| PL343677A1 (en) | 2001-08-27 |
| HUP0102116A2 (hu) | 2002-05-29 |
| WO1999055698A1 (en) | 1999-11-04 |
| IL139081A0 (en) | 2001-11-25 |
| BG104940A (bg) | 2001-09-28 |
| NO20005352L (no) | 2000-10-24 |
| KR20010042977A (ko) | 2001-05-25 |
| ZA200005912B (en) | 2001-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL323825A1 (en) | Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin | |
| PL348817A1 (en) | Compositions and methods for the treatment of anorectal disorders | |
| CY2431B1 (en) | Novel phenanthridines substituted in the 6 position. | |
| ZA200107689B (en) | 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders. | |
| EP0793489A4 (en) | AGENTS FOR TREATING SKIN DISEASES | |
| YU48698A (sh) | Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze | |
| EP0909561A3 (en) | Use of reboxetine for the treatment of attention-deficit/hyperactivity disorder | |
| IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
| ZA964762B (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders. | |
| ZA964761B (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders. | |
| AU1742200A (en) | Prevention and treatment of amyloid-associated disorders | |
| CY2482B1 (en) | Paroxetine in treatment of depression. | |
| IL154051A0 (en) | 4-,5-,6-, and 7-indole derivatives useful for the treatment of cns disorders | |
| AP2000001963A0 (en) | Paroxetine ascorbate. | |
| MXPA02011558A (es) | Inhibidores de mmp-2/mp-9 novedosos. | |
| SG148840A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
| BG104914A (en) | Paroxetine maleate | |
| IL128028A0 (en) | Treatment of psychotic disorders | |
| IL140540A0 (en) | Treatment of anxiety disorders | |
| NZ511997A (en) | Isonipecotamides for the treatment of integrin-mediated disorders | |
| ZA991144B (en) | Treatment of iron chloride. | |
| AP2000001958A0 (en) | Paroxetine 10-camphorsulfornate for treatment of CNS disorders. | |
| PL365576A1 (en) | S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders | |
| BG105252A (en) | Isoquinolines as urokinase inhibitors | |
| EP1143998A4 (en) | TREATMENT OF HYPERTENSION |